David Pyott is chairman and CEO of the global healthcare company Allergan. Headquartered in Irvine, California, Allergan provides speciality pharmaceutical products worldwide, developing and commercialising products in ophthalmology (a market in which it is the fastest growing company in the world), neurosciences, medical dermatology, medical aesthetics and other speciality markets. David Pyott joined Allergan in January 1998, as president and CEO. In 1998, he refocused the company’s strategy on specialty pharmaceuticals as well as restructuring Allergan’s worldwide operations. Savings from these streamlining programmes were reinvested into a major expansion of R&D and sales forces worldwide. In April 2001, Pyott was appointed chairman of the board of Allergan.
Before joining Allergan, Pyott was the head of the Novartis Nutrition Division and a member of the executive committee of the Switzerland-based company Novartis. He has a Diploma in German and European Law from the Europa Institute at the University of Amsterdam, a Master of Arts degree from the University of Edinburgh, and an MBA from London Business School.
Allergan has been on the forefront of aesthetic medicine developments. Their most popular brand ‘Botox’ is widely known all across the globe. Botox is excellent anti-wrinkle treatment. to have more information about Botox anti-wrinkle treatment click www.cosmedocs.com/treatments/botox-treatment.php
molanparker 5 years, 4 months and 15 days ago
Allergan has been on the forefront of aesthetic medicine developments. Their most popular brand ‘Botox’ is widely known all across the globe. Botox is excellent anti-wrinkle treatment. to have more information about Botox anti-wrinkle treatment click www.cosmedocs.com/treatments/botox-treatment.php
You must be a registered user to add a comment here. If you’ve already registered, please log in. If you haven’t registered yet, please register and log in.
Sign up to receive our latest news and business thinking direct to your inbox
London Business School takes your privacy seriously. We may process your personal information for carefully considered, specific purposes which enable us to enhance our services and benefit our customers. Please note that by subscribing now you may from time to time receive other emails from LBS about events or other activities that we think might interest you. View our Privacy Policy to learn more.
Thank you. You're almost ready to start enjoying Think. To verify your email and confirm your subscription please click on the link that we've sent to your email address.
Opps.. Something goes wrong. Please try again later.
This website uses cookies to distinguish you from other users. This helps us to provide you with a good user experience and also allows us to improve our website.
Privacy & Cookies Policy
David Pyott joined Allergan in January 1998, as president and CEO. In 1998, he refocused the company’s strategy on specialty pharmaceuticals as well as restructuring Allergan’s worldwide operations. Savings from these streamlining programmes were reinvested into a major expansion of R&D and sales forces worldwide. In April 2001, Pyott was appointed chairman of the board of Allergan.
molanparker 5 years, 4 months and 15 days ago
Allergan has been on the forefront of aesthetic medicine developments. Their most popular brand ‘Botox’ is widely known all across the globe. Botox is excellent anti-wrinkle treatment. to have more information about Botox anti-wrinkle treatment click www.cosmedocs.com/treatments/botox-treatment.php